Amikacin (250mg) + Cefepime (1gm)
CA 007 250 mg/1000 mg Injection is used in the treatment of bacterial infections.
10 ml in 1 vial
Themis Medicare Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
CA 007 250 mg/1000 mg Injection is a combination of two medicines: Amikacin and Cefepime. Amikacin is an antibiotic which stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions. Cefepime is also an antibiotic which works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Together, they eradicate your infection effectively.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
CA 007 250 mg/1000 mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
CA 007 250 mg/1000 mg Injection is safe to use during lactation. Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby.
Avoid prolonged use of CA 007 250 mg/1000 mg Injection, since it may have possible effects such as rash and diarrhea.
CA 007 250 mg/1000 mg Injection may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
CA 007 250 mg/1000 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of CA 007 250 mg/1000 mg Injection may be needed. Please consult your doctor.
CA 007 250 mg/1000 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of CA 007 250 mg/1000 mg Injection may not be needed in these patients. Please consult your doctor.
